FDA panel backs Glaxo asthma drug for adults, not adolescents
March 19, 2015 at 16:56 PM EDT
March 19 (Reuters) - GlaxoSmithKline Plc's drug to treat chronic breathing problems is safe and effective enough to be approved in adults with asthma but not adolescents, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.
